|
|
|
|
AG2037
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called glycinamide ribonucleotide formyl transferase inhibitors. (National Cancer Institute)
[an error occurred while processing this directive]
Additional Resources on AG2037 from the National Cancer Institute
[an error occurred while processing this directive]
|
|
|